期刊文献+

上调急性淋巴细胞白血病中细胞因子信号传导抑制因子3的表达促进NK细胞杀伤活性的机制研究 被引量:4

Expression Level of SOCS3 in Acute Lymphoblastic Leukemia Cells Affects the Cytotoxicity of NK Cells
原文传递
导出
摘要 目的:检测细胞因子信号传导抑制因子3(SOCS3)在急性淋巴细胞白血病(ALL)中的表达水平,并探讨NK细胞对过表达SOCS3细胞系Jurkat细胞的杀伤作用。方法:采用RT-PCR技术检测20例ALL患儿及20例健康体检儿童(正常对照组)外周血单个核细胞中SOCS3 mRNA表达水平。免疫磁珠分选健康人外周血NK细胞,采用流式细胞术检测其纯度。慢病毒载体感染Jurkat细胞使之过表达SOCS3,RT-PCR检测慢病毒感染后细胞中SOCS3 mRNA表达情况。将NK细胞与Jurkat细胞共培养,LDH释放法检测杀伤活性,ELISA检测TNF-α和IFN-γ浓度。流式细胞术检测过表达SOCS3后Jurkat细胞表面NKG2D配体MICA与MICB的表达。Western blot检测过表达SOCS3对Jurkat细胞中STAT3蛋白磷酸化水平的影响。结果:ALL患儿外周血单个核细胞中SOCS3 mRNA表达水平较正常对照组显著降低。流式细胞术检测分离NK细胞纯度可达70%以上。慢病毒感染的Jurkat细胞中SOCS3 mRNA表达显著增加。过表达SOCS3的Jurkat细胞可显著促进NK细胞对其杀伤能力,且可上调NK细胞TNF-α和IFN-γ的分泌。流式细胞术检测结果显示,过表达SOCS3后Jurkat细胞表面NKG2D配体MICA与MICB表达水平均显著增加。Western blot结果显示,过表达SOCS3后可显著降低Jurkat细胞中JAK/STAT信号通路中STAT3蛋白的磷酸化水平。结论:在ALL中SOCS3 mRNA表达显著降低,而过表达SOCS3可能通过负性调控JAK/STAT信号通路上调Jurkat细胞表面NKG2D配体MICA与MICB的表达,进而促进NK细胞的杀伤能力。 Objective: To detect the expression level of suppressors of cytokine signaling 3(SOCS3) in acute lymphoblastic leukemia(ALL), and to observe the effect of over-expresson of SOCS3 in Jurkat cells on the cytotoxicity of NK cells. Methods: The expression levels of SOCS3 mRNA in peripheral blood mononuclear cells of 20 children with ALL and 20 healthy children(normal control group) were detected by RT-PCR. The peripheral blood NK cells from healthy subjects were selected by immunomagnetic technique, and the purity was detected by flow cytometry. SOCS3 was overexpressed in Jurkat cells infected with lentivirus vector, and SOCS3 mRNA expression was detected by RT-PCR after lentivirus infection. The NK cells were co-cultured with the infected Jurkat, and LDH release method was used to detect the cytotoxicity of NK cells on the infected Jurkat cells. The concentrations of TNF-α and IFN-γ were determined by ELISA. The expression of NKG2 D ligands MICA and MICB on the surface of Jurkat cells were detected by flow cytometry. Western blot was used to detect the effect of SOCS3 overexpression on STAT3 phosphorylation in Jurkat cells. Results: Compared with the control group, the mRNA expression of SOCS3 in the peripheral blood mononucleated cells of ALL children was significantly decreased. The purity of NK cells isolated by flow cytometry could reach more than 70%. The expression of SOCS3 mRNA in Jurkat cells increased significantly after lentivirus infection. Overexpression of SOCS3 in Jurkat cells significantly promoted the killing ability of NK cells and up-regulated the secretion of TNF-α and IFN-γ from NK cells. The results of flow cytometry showed that the expression of NKG2 D ligands M ICA and M ICB on Jurkat cells increased significantly after SOCS3 overexpression. Western blot results show ed that overexpression of SOCS3 significantly reduced the phosphorylation level of STAT3 protein in Jurkat cells.Conclusion: SOCS3 mRNA expression w as significantly decreased in ALL patients,and overexpression of SOCS3 may up-regulate the expression of M ICA and M ICB of NKG2 D ligands on Jurkat cell surface through negative regulation of JAK/STAT signaling pathw ay,thereby promoting the cytotoxic function of NK cells.
作者 唐冰 李永格 程琳 党惠兵 TANG Bing;LI Yong-Ge;CHENG Lin;DANG Hui-Bing(Clinical Deparment of Nanyang Medical College,Nanyang 473061,Henan Province,China;Deparimentof Hematology,The First Affiliated Hospital of Nanyang Medical College,Nanyang 73000,Henan Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2022年第2期400-406,共7页 Journal of Experimental Hematology
基金 河南省科技攻关项目(212102310837)。
关键词 急性淋巴细胞白血病 细胞因子信号传导抑制因子3 自然杀伤细胞 JAK/STAT信号通路 acute lymphoblastic leukemia SOCS3 NK cells JAK/STAT signaling pathway
  • 相关文献

参考文献6

二级参考文献49

  • 1刘映霞,邹文华,朱金台,李红梅.乙型肝炎患者外周血单个核细胞中HBV DNA与HBV血清标志的关系[J].中华传染病杂志,1997,15(2):99-100. 被引量:5
  • 2Vardiman JW, World Health neoplasms and Blood, 2009, Thiele J, Arber DA, et al. The 2008 revision of the Organization (WHO) classification of myeloid acute leukemia: rationale and important changes [J]. 114 (5): 937-951.
  • 3Drexler HG, Macleod RA. History of leukemia-lymphoma cell lines [J]. Hum Cell, 2010, 23 (3): 75-82.
  • 4Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents [J]. Nat Rev Cancer, 2010, 10(4): 241-253.
  • 5Rosenfeld C, Goutner A, Choquet C, et al. Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line [J]. Nature, 1977, 267(5614) : 841-843.
  • 6Matsuo Y, Drexler HG. Establishment and characterization of human B cell precursor-leukemia cell lines [ J ]. Leuk Res, 1998, 22 (7) : 567-579.
  • 7Zhang LQ, Downie PA, Goodell WR, et al. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia [J]. Leukemia, 1993, 7( 11 ) : 1865-1874.
  • 8Faded S, Albitar M. Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia[ J ]. Hematol Oncol Clin North Am, 2000, 14(6): 1267-1288.
  • 9Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762) [J]. Blood, 1992, 80 (12) : 2983-2990.
  • 10Gleissner B, Gtikbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Muhicenter Trial Group and confirmed polymerase chain reaction analysis[J]. Blood, 2002, 99(5): 1536-1543.

共引文献28

同被引文献51

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部